Cannabis use in young people: the risk for schizophrenia
- PMID:21530584
- DOI: 10.1016/j.neubiorev.2011.04.007
Cannabis use in young people: the risk for schizophrenia
Abstract
Cannabis is one of the most commonly used illicit drugs, and despite the widely held belief that it is a safe drug, its long-term use has potentially harmful consequences. To date, the research on the impact of its use has largely been epidemiological in nature and has consistently found that cannabis use is associated with schizophrenia outcomes later in life, even after controlling for several confounding factors. While the majority of users can continue their use without adverse effects, it is clear from studies of psychosis that some individuals are more vulnerable to its effects than others. In addiction, evidence from both epidemiological and animal studies indicates that cannabis use during adolescence carries particular risk. Further studies are warranted given the increase in the concentration of the main active ingredient (Δ(9)-tetrahydrocannabinol) in street preparations of cannabis and a decreasing age of first-time exposure to cannabis.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
- Does using marijuana increase the risk for developing schizophrenia?Evins AE, Green AI, Kane JM, Murray RM.Evins AE, et al.J Clin Psychiatry. 2013 Apr;74(4):e08. doi: 10.4088/JCP.12012tx2c.J Clin Psychiatry. 2013.PMID:23656852
- [Adolescent cannabis consumption and schizophrenia: epidemiological and experimental evidences].Parolaro D.Parolaro D.Adicciones. 2010;22(3):185-9.Adicciones. 2010.PMID:20802980Spanish.
- Adverse effects of cannabis.[No authors listed][No authors listed]Prescrire Int. 2011 Jan;20(112):18-23.Prescrire Int. 2011.PMID:21462790Review.
- [Psychiatric complications of cannabis use].Coscas S, Benyamina A, Reynaud M, Karila L.Coscas S, et al.Rev Prat. 2013 Dec;63(10):1426-8.Rev Prat. 2013.PMID:24579344Review.French.
- Adverse effects of cannabis on health: an update of the literature since 1996.Kalant H.Kalant H.Prog Neuropsychopharmacol Biol Psychiatry. 2004 Aug;28(5):849-63. doi: 10.1016/j.pnpbp.2004.05.027.Prog Neuropsychopharmacol Biol Psychiatry. 2004.PMID:15363608Review.
Cited by
- Concurrent and Sustained Cumulative Effects of Adolescent Marijuana Use on Subclinical Psychotic Symptoms.Bechtold J, Hipwell A, Lewis DA, Loeber R, Pardini D.Bechtold J, et al.Am J Psychiatry. 2016 Aug 1;173(8):781-9. doi: 10.1176/appi.ajp.2016.15070878. Epub 2016 May 3.Am J Psychiatry. 2016.PMID:27138587Free PMC article.
- Endocannabinoid metabolism in the prefrontal cortex in schizophrenia.Volk DW, Siegel BI, Verrico CD, Lewis DA.Volk DW, et al.Schizophr Res. 2013 Jun;147(1):53-57. doi: 10.1016/j.schres.2013.02.038. Epub 2013 Apr 2.Schizophr Res. 2013.PMID:23561296Free PMC article.
- Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposure.Salo R, Fassbender C, Iosif AM, Ursu S, Leamon MH, Carter C.Salo R, et al.Psychiatry Res. 2013 Dec 15;210(2):529-35. doi: 10.1016/j.psychres.2013.06.030. Epub 2013 Jul 26.Psychiatry Res. 2013.PMID:23896355Free PMC article.
- Cannabis Use during Adolescent Development: Susceptibility to Psychiatric Illness.Chadwick B, Miller ML, Hurd YL.Chadwick B, et al.Front Psychiatry. 2013 Oct 14;4:129. doi: 10.3389/fpsyt.2013.00129.Front Psychiatry. 2013.PMID:24133461Free PMC article.Review.
- Perineuronal nets and schizophrenia: the importance of neuronal coatings.Bitanihirwe BK, Woo TU.Bitanihirwe BK, et al.Neurosci Biobehav Rev. 2014 Sep;45:85-99. doi: 10.1016/j.neubiorev.2014.03.018. Epub 2014 Apr 4.Neurosci Biobehav Rev. 2014.PMID:24709070Free PMC article.Review.
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Medical